期刊文献+

血清尿酸与非高密度脂蛋白胆固醇检测在冠心病预测、评价中的意义

Significance of the Detection of Serum Uric Acid and Non-High Density Lipoprotein Cholesterol in the Prediction and Evaluation of Coronary Heart Diseases
下载PDF
导出
摘要 目的分析血清尿酸(UA)、非高密度脂蛋白胆固醇(non-HDL-C)及其他血脂指标在冠心病患者中的变化及意义。方法随机选取冠心病(CHD)患者293例及147例体检健康者(对照组),测定血清尿酸、血脂,计算non-HDL-C值,采用SPSS软件进行统计学分析。结果CHD组UA、non-HDL-C、甘油三酯(TG)浓度明显高于对照组(P<0.01);低密度脂蛋白胆固醇(LDL-C)、脱辅基蛋白B(aPoB)浓度高于对照组(P<0.05);载脂蛋白-AI(aPoA-I)、高密度脂蛋白胆固醇(HDL-C)水平显著低于对照组(P<0.01);经多元素logistie回归分析发现non-HDL-C与CHD发生关系最密切,其次为UA、TG、LDL-C等。结论non-HDL-C比LDL-C对CHD的发生有更好的预测评价作用。高尿酸血症可能是CHD发生的又一危险因素。 [ Objective ] To analyze the clinical value of serum uric acid, non-high density lipoprotein cholesterol ( HDL C )and other blood index among the patients of coronary heart diseases (CHD). [ Methods] 293 CHD cases and 147 healthy people were stochastically collected ; detection was made on their serum uric acid and blood lipid; non HDL C value was calculated ; statistical anal- ysis was made with SPSS software. [ Results] The levels of serum uric acid, non HDL C value and total cholesterol (TC) of the CHD group were obviously higher than that of the control ( P 〈 0.01 ) ; the levels of low density lipoprotein cholesterol ( LDL C) and aPoB were higher than that of the control ( P 〈 0.05 ) ; the levels of aPoA-I and HDL C were significantly lower than that of the con- trol ( P 〈0.01 ) ; the logistic regression analysis found that non HDL C had the closest relationship with CHD, then with UA, TG, LDL C and so on. [ Conclusion] Non HDL C can more effectively predict and evaluate the occurrence of CHD than LDL C; high serum UA might be another risk factor for CHD.
出处 《职业与健康》 CAS 2008年第24期2664-2665,共2页 Occupation and Health
关键词 冠心病 尿酸 非高密度脂蛋白胆固醇 Non-high density lipoprotein cholesterol Uric acid Coronary heart disease
  • 相关文献

参考文献6

二级参考文献10

  • 1Executive Summary of the Third Report of The National Cholesterol Education Program(NCEP) Expert panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults, Adult Treatment Panel Ⅲ.Final Report. Circulation, 2002,106:3143-3420.
  • 2Gardner CD, Winklerby MA, Fortmann SP. Population frequency distribution of non-high density lipoprotein cholesterol (Third National Health and Nutrition Examination survey [NHANES Ⅲ] 1988-1994). Am J Cardiol, 2000, 86:299-304.
  • 3Bitter V,Hocrdison R, Kelsey SF, et al. Non-high density lipoprotein cholesterol levels predict five-year outcome in the bypass angioplasty revascularization investigation (BARI). Circulation, 2002,106:2537-2542.
  • 4Forst PH, Havel RJ. Rational for use of non-high density lipoprotein cholesterol rather than low density lipoprotein cholesterol as a tool for lipoprotein cholesterol screening and assessment of risk and therapy. Am J Cardiol, 1998, 81 (4A): 26B-31B.
  • 5Grundy SM. Low density lipoprotein, non-high density lipoprotein and apolipoprotein B as targets of lipid lowering therapy. Circulation, 2002, 106:2526-2529.
  • 6van-Hecke MV,Dekker JM,Nijpels G,et al.Inflammation and endothelial dysfunction are associated with retinopathy:the Hoorn Study[J].Diabetologia,2005,48(7):1300
  • 7Woodman RJ,Watts GF,Puddey IB,et al.Leukocyte count and vascular function in Type 2 diabetic subjects with treated hypertension[J].Atherosclerosis,2002,163(1):175
  • 8Pickup JC,Crook MA.Is type Ⅱ diabetes mellitus a disease of the innate immune system[J].Diabetologia,1998,41(10):1241
  • 9Ajjan R,Grant PJ,Futers TS,et al Complement C3 and C-reactive protein levels in patients with stable coronary artery disease[J].Thromb Haemost,2005,94(5):1048
  • 10The Diabetes Prevention Program Research Group.Lipid,lipoproteins,C-reactive protein,and hemostatic factors at baseline in the diabetes prevention program[J].Diabetes Care,2005,28(10):2472

共引文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部